Coronavirus and Drug Shortage – A Tale of Two Crises

 

On February 4, 2020, FDA issued a press release regarding the issuance of an emergency use authorization (EUA) (here) to allow for emergency use of a Coronavirus diagnostic panel by Centers for Disease Control and Prevention (CDC)-qualified labs across the country.  Previously, the panel’s use was limited to only CDC laboratories.